4,5-Diiodophthalonitrile

Catalog No.: 
ACFDBD145
CAS No.: 
175883-98-4
Molecular Formula: 
null
Molecular Weight: 
379.93
4,5-Diiodophthalonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$176.00In stockInquiry
100mg97%$258.00In stockInquiry
250mg97%$393.00In stockInquiry
1g97%$1072.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5-Diiodophthalonitrile
IUPAC Name4,5-Diiodophthalonitrile
MDL No.MFCD30474913
Molecular Formulanull
Molecular Weight379.93
SMILESN#CC1=CC(I)=C(I)C=C1C#N
InChI KeyAPCUAIZUAMXEKR-UHFFFAOYSA-N
Synonym4,5-diiodophthalodinitrile;1,2-Benzenedicarbonitrile, 4,5-diiodo-;4,5-Diiodophthalonitrile
CAS No.175883-98-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFDBD145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACFDBD145 route product structure diagram
    ACFDBD145175883-98-4In Stock
Inquiry

2. ACFDBD145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACFDBD145 route product structure diagram
    ACFDBD145175883-98-4In Stock
Inquiry

3. ACFDBD145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFDBD145 route product structure diagram
    ACFDBD145175883-98-4In Stock
Inquiry

Comments (0)